Highlights
NASDAQ: KURA       Kura Oncology
Last Price Today's Change   Day's Range   Trading Volume
14.85   +0.08 (0.54%)  14.525 - 15.05  271,116

Overview

 
Avg Volume (4 weeks):269,431
4 Weeks Range:14.39 - 16.68
4 Weeks Price Volatility (%):
20.09%
52 Weeks Range:12.30 - 21.42
52 Weeks Price Volatility (%):
27.96%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through United States.

  Be the first to like this.
 


 

3642  2100  311  2918 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.038 
 BAC 34.68+1.04 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers